This article was originally published in The Gray Sheet
Investment banker Sutro & Co. is engaged as a financial advisor to assist the company "in reviewing various financial alternatives and developing strategic relationships, including, but not limited to, securing partnerships with pharmaceutical companies," Immunomedics states. The Morris Plains, New Jersey biopharmaceutical firm is focused on diagnostic imaging and therapeutic products for detection and treatment of cancer and infectious diseases. Its CEA-Scan (arcitumomab) imaging agent for detection of colorectal cancer is available in the U.S. and Europe, and its LeukoScan (sulesomab) agent is marketed in Europe and pending FDA approval for diagnosis of osteomyelitis
You may also be interested in...
Health technology assessment body says that while iRhythm Technologies’ Zio XT service improves cardiac arrhythmia detection, more data must be collected to address evidence gaps about its benefit.
UK start-up Iceni Diagnostics has secured funding to develop its test for the live, intact SARS-CoV-2 virus and the UK government is evaluating a lateral flow device based on the technology for testing saliva samples as part of efforts to step up rapid testing in the country. See what Iceni’s CEO Rob Field said about it here.
The run-away US FDA advisory committee review of Biogen’s Alzheimer’s candidate was highly unusual. But like most things at the agency, not entirely unprecedented.